Markets

Abeona Therapeutics (ABEO) Surges: Stock Moves 7.2% Higher

An image of stock prices rising and declining in value
Credit: Shutterstock photo

Abeona Therapeutics Inc.ABEO was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company-as the stock is now up 4.1% in the past one-month time frame.

The move came after the company announced that it has priced an underwritten public offering of five million shares of common stock at a public offering at $16 per share, which is expected to generate gross proceeds of roughly $80 million.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Abeona Therapeutics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Abeona Therapeutics Inc. Price

Abeona Therapeutics Inc. Price | Abeona Therapeutics Inc. Quote

Investors interested in the Medical - Biomedical and Genetics industry may consider Axovant Sciences Ltd. AXON , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here .

Is ABEO going up? Or down? Predict to see what others think: Up or Down

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Axovant Sciences Ltd. (AXON): Free Stock Analysis Report

Abeona Therapeutics Inc. (ABEO): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ABEO

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More